Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)

Edina Cenko*, Lina Badimon, Raffaele Bugiardini, Marc J Claeys, Giuseppe De Luca, Cor de Wit, Geneviève Derumeaux, Maria Dorobantu, Dirk J Duncker, Etto C Eringa, Diana A Gorog, Christian Hassager, Frank R Heinzel, Kurt Huber, Olivia Manfrini, Davor Milicic, Evangelos Oikonomou, Teresa Padro, Danijela Trifunovic-Zamaklar, Zorana Vasiljevic-PokrajcicMarija Vavlukis, Gemma Vilahur, Dimitris Tousoulis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2705-2729
Number of pages25
JournalCardiovascular Research
Volume117
Issue number14
DOIs
Publication statusPublished - 17 Dec 2021

Keywords

  • Angiotensin-Converting Enzyme 2/metabolism
  • COVID-19/complications
  • Cardiometabolic Risk Factors
  • Cardiovascular Diseases/enzymology
  • Clinical Trials as Topic
  • Humans
  • Inflammation/complications
  • Microcirculation
  • Sex Characteristics
  • CARDIOLOGY
  • Cardiovascular disease
  • CARDIAC ARREST SYNDROME
  • endothelial dysfunction
  • ANGIOTENSIN-CONVERTING ENZYME
  • THROMBOEMBOLISM FOLLOWING HOSPITALIZATION
  • COVID-19
  • SARS-CoV-2
  • thrombosis
  • inflammation
  • cytokines
  • POSITION PAPER
  • CORONAVIRUS
  • post-acute COVID-19
  • microcirculation
  • Infection
  • MYOCARDIAL INJURY
  • SEX-DIFFERENCES
  • INFLAMMATORY RESPONSE
  • EXPRESSION
  • Myocardial injury

Cite this